In early March, Eli Lilly made headlines after announcing a new $35 price cap on insulin for individuals with private insurance. Novo Nordisk and Sanofi made their own price reduction announcements shortly after Eli Lilly’s move.
Tag: Eli Lilly
Eli Lilly ‘just the first shoe to drop’ in drug cost changes
Drugmaker Eli Lilly and Company announced it would significantly reduce the prices of several of its insulin products and cap patient insulin out-of-pocket costs at $35 per month. Nick Fabrizio, professor of health policy at Cornell University, says this is…
Project to improve health equity in Indianapolis expands with funding from Lilly
Indiana University has received a five-year, $5 million grant from Eli Lilly and Co. to expand the Diabetes Impact Project, which aims to improve health equity in three Indianapolis neighborhoods where residents are predominantly people of color.